Europe Psychedelic Drugs Market to Witness Impressive Expansion of USD 607.39 Million with a Growing CAGR of 12.7% by 2029
Europe Psychedelic Drugs Market report is a definitive solution for sound decision making and superior management of goods and services. This market research report endows clients with the supreme level of market data and information which exactly matches to the niche and business requirements. This Europe Psychedelic Drugs market research report delivers all-inclusive analysis of the market structure along with the estimations of the various segments and sub-segments of the market.
Europe Psychedelic Drugs market report also analyses the market status, market share, current trends, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. For market segmentation study, a market of potential customers is divided into groups or segments based on different characteristics such as end user and geographical region. This Europe Psychedelic Drugs Market report brings precise and exact market research information that drives your business into the correct direction.
Grab Sample Report with Complete Graphs, Charts and Figures @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-psychedelic-drugs-market
Europe psychedelic drugs market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.7% in the forecast period of 2022 to 2029 and is expected to reach USD 607.39 million by 2029 from USD 235.71 million in 2021.
Market Outline: –
Psychedelic drugs involve various types of chemical substances including lysergic acid diethylamide (LSD) and chemical extracted from plants. These drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences.
The psychedelic drugs can be categorized into empathogens and dissociative drugs (such as phenylcyclohexyl piperidine (PCP)) and serotonergic (classic hallucinogens) such as LSD. Both types of psychedelic drugs can cause hallucinations and feeling of sensation, moreover, dissociative drugs can make a person to fell out of control from their body or environment and makes them feel disconnected. Based on the source, psychedelic drugs have been categorized under natural and synthetic types.
These drugs have wide applications in the treatment of major depressive disorder, post-traumatic stress disorder, panic disorder, treatment-resistant depression and opiate addiction among others. Psychedelic drugs are also known by several other names such as lysergic acid derivative (LSD) which are also known as blotter, dots, sugar, acid, trips and window pane, ketamine are also known as vitamin K, bump, green, K/special K, purple and super acid, PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.
Some of the major players operating in the Europe Psychedelic Drugs market are
Jazz Pharmaceuticals, Inc., Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, COMPASS, Verrian, Pfizer Inc., F. Hoffmann-La Roche Ltd, Avadel, Celon Pharma SA., Cybin Corp., GH Research, Entheon Biomedical Corp, among others.
Access Full 350 Pages PDF Report @ https://www.databridgemarketresearch.com/reports/europe-psychedelic-drugs-market
Recent Development
- In August 2020, Janssen Pharmaceuticals, Inc. received approval for its Spravato nasal spray indicated for treatment of suicidal people. As approximately 11% to 12% of Americans suffers from major depressive disorder that led them to commit suicide, this approval provided these patients with a remarkable therapy and paved the way for the company to generate more revenue
Table of Content:
Section 01: Executive Summary
Section 02: Scope of The Report
Section 03: Research Methodology
Section 04: Introduction
Section 05: Market Landscape
Section 06: Market Sizing
Section 07: Five Forces Analysis
Section 08: Market Segmentation by Product
Section 09: Market Segmentation by Application
Section 10: Customer Landscape
Section 11: Market Segmentation by End-User
Section 12: Regional Landscape
Section 13: Decision Framework
Section 14: Drivers and Challenges
Section 15: Market Trends
Section 16: Competitive Landscape
Section 17: Company Profiles
Section 18: Appendix
For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=europe-psychedelic-drugs-market
Europe Psychedelic Drugs Market Scope
Europe psychedelic drugs market is segmented into source, type, drugs, application, route of administration, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Source
- Synthetic
- Natural
On the basis of source, the Europe psychedelic drugs market is segmented into synthetic and natural.
Type
- Empathogens
- Dissociatives
- Others
On the basis of type, the Europe psychedelic drugs market is segmented into empathogens, dissociatives, and others.
Drugs
- Gamma-Hydroxybutyric Acid
- Ketamine
- Psilocybin
- Others
On the basis of drugs, the Europe psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others.
..Application
- Narcolepsy,
- Treatment Resistant Depression
- Major Depressive Disorder
- Opiate Addiction
- Post-Traumatic Stress Disorder
- Others
On the basis of application, the Europe psychedelic drugs market is segmented into narcolepsy, treatment resistant depression, major depressive disorder, opiate addiction, post-traumatic stress disorder and others.
Route of Administration
- Oral
- Inhalation
- Injectable
On the basis of route of administration, the Europe psychedelic drugs market is segmented into oral, inhalation, injectable.
End User
- Hospital
- Specialty Clinics
- Homecare
- Others
On the basis of end user, the Europe psychedelic drugs market is segmented into hospital, specialty clinics, homecare, and others.
Distribution Channel
- Hospitals Pharmacy
- Retail Pharmacy
- Online Pharmacy
Reasons to Consider This Report?
- The report offers a comprehensive evaluation of the Europe Psychedelic Drugs market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.
The Study Objectives of the Europe Psychedelic Drugs Market Research Report are:
- To examine deeply on the existing status, future forecast, growth opportunity, key market and industry players.
- To display the current development in major economies, across the globe.
- To strategically profile the market players and comprehensively examine their growth and development plans.
- To define, describe and predict the Europe Psychedelic Drugs Market by product type, application, end user, and key regions.
Browse Trending Reports:
Psychedelic Drugs Market Size, Share, Growth and Opportunities https://www.databridgemarketresearch.com/reports/global-psychedelic-drugs-market
Middle East And Africa Psychedelic Drugs Market Size, Share, Growth and Opportunities https://www.databridgemarketresearch.com/reports/middle-east-and-africa-psychedelic-drugs-market
North America Psychedelic Drugs Market Size, Share, Growth and Opportunities https://www.databridgemarketresearch.com/reports/north-america-psychedelic-drugs-market
Asia Pacific Psychedelic Drugs Market Size, Share, Growth and Opportunities https://www.databridgemarketresearch.com/reports/asia-pacific-psychedelic-drugs-market
Us Psychedelic Drugs Market Size, Share, Growth and Opportunities https://www.databridgemarketresearch.com/reports/us-psychedelic-drugs-market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
